Literature DB >> 2076991

Substrate utilization during acute exercise in obese Zucker rats.

C E Torgan1, J T Brozinick, M E Willems, J L Ivy.   

Abstract

The purpose of the present study was to compare the carbohydrate use of insulin-resistant obese Zucker rats with that of their lean littermates during steady-state exercise. Obese and lean rats were randomly assigned to a sedentary group or to a run group in which rats ran at 72-73% of their maximal O2 consumption, with the duration of exercise set to require an energy expenditure of 2.1-2.2 kcal. During the run the respiratory exchange ratio was significantly higher in the obese than in the lean rats [0.94 +/- 0.01 (SE) and 0.86 +/- 0.01, respectively], which indicate that the obese rats required 54% more carbohydrate than the lean rats. Total muscle glycogen utilization in the soleus, plantaris, and red and white gastrocnemius was not different between groups. Obese rats had total liver glycogen values five times greater than those of lean rats (833.38 +/- 101.4 and 152.8 +/- 37.5 mg, respectively) and utilized twice as much liver glycogen as their lean littermates (193.5 and 90.4 mg, respectively). The obese rats exhibited higher blood glucose and insulin concentrations than the lean rats during the run. These findings indicate that, despite their characteristic insulin resistance, the obese Zucker rats had a greater dependency on carbohydrate as a substrate during exercise than their lean littermates and that the major source of this carbohydrate was liver glycogen.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2076991     DOI: 10.1152/jappl.1990.69.6.1987

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  1 in total

1.  Metabolomics reveals mouse plasma metabolite responses to acute exercise and effects of disrupting AMPK-glycogen interactions.

Authors:  Mehdi R Belhaj; Nathan G Lawler; John A Hawley; David I Broadhurst; Nolan J Hoffman; Stacey N Reinke
Journal:  Front Mol Biosci       Date:  2022-08-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.